Clinical Trials Sponsored by Tyme, Inc

Total 35588 results

Tyme, Inc

Completed

A Randomized Phase 2/3 Multi-Center Study of SM-88 in Patients With Metastatic Pancreatic Cancer

Pancreatic Cancer

United States
Tyme, Inc

Completed

Study of the Efficacy, Safety, and Pharmacokinetics of SM88 in Patients With Prostate Cancer

Prostate Cancer | Rising Prostate Specific Antigen (PSA)

United States
Tyme, Inc

Withdrawn

Study of SM-88 in Advanced Cancers

Breast Cancer
Georgetown University
Tyme, Inc

Terminated

Oral SM-88 in Patients With Metastatic HR+/HER2- Breast Cancer (OASIS)

Breast Cancer | Metastatic Breast Cancer | Hormone Receptor Positive Breast Carcinoma

United States
Ryme Medical, Inc.

Not yet recruiting

Ryme Medical TLD Pilot Study

Chronic Obstructive Pulmonary Disease
Sarcoma Oncology Research Center, LLC
Tyme, Inc

Active, not recruiting

SM-88 Maintenance Therapy for Advanced Ewing's Sarcoma and as Salvage Therapy for Sarcoma (HopES)

Sarcoma | Sarcoma, Ewing

United States
Team Type 1, Inc.

Unknown

Glycemic Response to Road Cycling in Type 1 Diabetes

Type 1 Diabetes
Real Time Diagnostics Ventures INC

Withdrawn

Hemp-Derived Botanical Dietary Supplementation During Recovery From Brain Injury

Traumatic Brain Injury
Hancock Jaffe Laboratiores, Inc
Syntactx; AXIOM Real Time Metrics

Recruiting

The Hancock Jaffe Surgical Antireflux Venous Valve Endoprosthesis Study

Deep Venous Insufficiency (Diagnosis)

United States
TME Pharma AG

Completed

First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NOX-H94

Inflammation | Anemia | Chronic Diseases

United Kingdom
TME Pharma AG

Completed

NOX-A12 Multiple Ascending Dose Study in Healthy Volunteers (SNOXA12C101)

Hematopoietic Stem Cell Transplantation

Germany
TME Pharma AG

Completed

NOX-E36 First-in-Human (FIH) Study

Type 2 Diabetes Mellitus | Systemic Lupus Erythematosus | Chronic Inflammatory Diseases
Newcastle-upon-Tyne Hospitals NHS Trust
University of Newcastle Upon-Tyne

Unknown

Association of Capecitabine Pharmacokinetics and Toxicity With Aging

Breast Cancer | Colorectal Cancer
TME Pharma AG

Active, not recruiting

Glioblastoma Treatment With Irradiation and Olaptesed Pegol (NOX-A12) in MGMT Unmethylated Patients (GLORIA)

Glioblastoma

Germany
TME Pharma AG

Completed

Efficacy of NOX-H94 on Anemia of Chronic Disease in Patients With Cancer

Anemia of Chronic Disease

Bulgaria, Romania, Austria
TME Pharma AG

Completed

A Phase I Clinical Trial to Evaluate the Effect of Renal Impairment on Pharmacokinetics of NOX-E36

Renal Impairment

Hungary, Moldova, Republic of
TME Pharma AG

Completed

NOX-A12 in Combination With Bendamustine and Rituximab in Relapsed Chronic Lymphocytic Leukemia (CLL)

Chronic Lymphocytic Leukemia

Belgium, Austria, Italy, France
TME Pharma AG

Completed

Lexaptepid Pegol (NOX-H94) in ESA-hyporesponsive Anemia in Dialysis Patients

Anemia | End Stage Renal Disease

United Kingdom, Germany, Italy
TME Pharma AG

Completed

NOX-A12 in Combination With Bortezomib and Dexamethasone in Relapsed Multiple Myeloma

Multiple Myeloma

Austria, France, Germany, Italy
TME Pharma AG

Completed

Pharmacokinetics/Pharmacodynamics of NOX-H94 in the Human Endotoxemia Model

Anemia of Chronic Disease

Netherlands
TME Pharma AG

Completed

NOX-E36 in Patients With Type 2 Diabetes Mellitus and Albuminuria

Type 2 Diabetes Mellitus | Albuminuria

Poland, Germany, Romania, Hungary, Czech Republic
Lyme Diagnostics Ltd.
Pharmahungary Group

Completed

Performance Evaluation of the DualDur In Vitro Diagnostic System in the Diagnosis of Lyme Borreliosis

Lyme Borreliosis

Austria, Czechia, Germany, Hungary, Poland, Slovakia
Newcastle-upon-Tyne Hospitals NHS Trust
Newcastle University; DSM Nutritional Products, Inc.

Completed

Effect of SNPs in the BCMO1 Enzyme (BETASNP2)

Vitamin A Deficiency | Beta-carotene Bioavailability

United Kingdom
Shandong New Time Pharmaceutical Co., LTD

Recruiting

Efficacy and Safety Study of F520 Combined With Lenvatinib in the Treatment of Patients With Advanced Solid Tumors

Solid Tumors

China
Shandong New Time Pharmaceutical Co., LTD

Not yet recruiting

A Phase III Clinical Study of Minodronate Tablets in Postmenopausal Women With Osteoporosis

Osteoporosis

China
Shandong New Time Pharmaceutical Co., LTD

Not yet recruiting

Study of F527 in Patients With Relapsed or Refractory Lymphoma

Relapsed/Refractory Lymphoma

China
Newcastle-upon-Tyne Hospitals NHS Trust

Recruiting

Global Registry for COL6-related Dystrophies

Bethlem Myopathy | Ullrich Congenital Muscular Dystrophy 1, Digenic, Col6A1/Col6A2 | Ullrich Congenital Muscular Dystrophy 1, Autosomal Recessive | Ullrich Congenital Muscular Dystrophy 1, Autosomal Dominant | Bethlem Myopathy 1, Autosomal Recessive | UCMD | BTHLM1

United Kingdom
Shandong New Time Pharmaceutical Co., LTD

Completed

A Phase IV Study of Huazhi Rougan Granule in the Treatment of Non-alcoholic Simple Fatty Liver

Efficacy and Safety

China
Newcastle-upon-Tyne Hospitals NHS Trust

Terminated

Assessment of Frailty in Elderly Patients With Advanced Cancers (FAC-C)

Cancer

United Kingdom
Shandong New Time Pharmaceutical Co., LTD

Unknown

A Phase Ⅱ Study of F520 in Patients With Urothelial Carcinoma

Locally Advanced or Metastatic Urothelial Cell Carcinoma
Shandong New Time Pharmaceutical Co., LTD

Unknown

The Efficacy and Safety of F520 in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma (PTCL).

Peripheral T Cell Lymphoma
Newcastle-upon-Tyne Hospitals NHS Trust

Unknown

Tissue Vascular Optics and Impedance Measurements for the Detection of Early Tissue Damage and Pressure Ulceration (OPUS)

Pressure Ulcer

United Kingdom
Newcastle-upon-Tyne Hospitals NHS Trust

Completed

A Study to Improve Cardiovascular Outcomes in High Risk PatieNts With Acute Coronary Syndrome (ICON1)

Acute Coronary Syndrome

United Kingdom
Newcastle-upon-Tyne Hospitals NHS Trust

Completed

Cardiac Energetics and Function in Normal Human Ageing

Left Ventricular Function Systolic Dysfunction | Left Ventricular Function Diastolic Dysfunction | Ageing

United Kingdom
Newcastle-upon-Tyne Hospitals NHS Trust

Completed

Assessment of Lumen Expansion After Thrombus Extraction in Primary Percutaneous Coronary Intervention (INVEST-MI)

Acute ST Elevation Myocardial Infarction

United Kingdom
Newcastle-upon-Tyne Hospitals NHS Trust

Unknown

Association of Fear of Falling and Physical Activity in Rheumatoid Arthritis Comparison Before and After Biological Therapy

Rheumatoid Arthritis

United Kingdom
Newcastle-upon-Tyne Hospitals NHS Trust
British Heart Foundation; University of Newcastle Upon-Tyne

Completed

Assessment of Thrombogenicity in Acute Coronary Syndrome

Type 2 Diabetes Mellitus | Acute Coronary Syndrome

United Kingdom
Newcastle-upon-Tyne Hospitals NHS Trust
British Heart Foundation; University of Newcastle Upon-Tyne

Completed

Platelet-dependent Thrombosis: a Placebo-controlled Trial of Antiplatelet Therapy (Clopidogrel)

Coronary Artery Disease | Type 2 Diabetes Mellitus

United Kingdom
Shandong New Time Pharmaceutical Co., LTD

Not yet recruiting

A Phase II Study of Rulonilimab Combined With Chemotherapy in the First-Line Treatment for Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

NSCLC | Non-small Cell Lung Cancer | PD-1

China
Shandong New Time Pharmaceutical Co., LTD

Recruiting

the Efficacy and Safety of Rulonilimab in Combination With Lenvatinib in Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma

China
Shandong New Time Pharmaceutical Co., LTD

Not yet recruiting

A Phase II Study to Evaluate the Efficacy and Safety of F520 Combined With F007 in Patients With RR DLBCL

RR DLBCL; PD-1; CD20
Shandong New Time Pharmaceutical Co., LTD

Recruiting

A Study Comparing the Efficacy and Safety Between H-CHOP and R-CHOP in Untreated CD20-Positive Diffuse Large B-cell Lymphoma Patients

Recruiting

China
Shandong New Time Pharmaceutical Co., LTD

Completed

A Phase IV Study of Huazhi Rougan Granule

A Phase IV Trial to Investigate the Efficacy and Safety of Huazhi Rougan Granule in the Treatment of Non-alcoholic Simple Fatty Liver

China
Newcastle-upon-Tyne Hospitals NHS Trust

Completed

Testosterone Therapy for Pubertal Delay in Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy

United Kingdom
Shandong New Time Pharmaceutical Co., LTD

Unknown

Phase Ⅰ Study to Evaluate the Safety and Tolerability of Using F520

Advanced Solid Tumor，Recurrent Solid Tumor，Lymphoma，Recurrent Lymphocyte Depleted Classical Hodgkin Lymphoma

China
Newcastle-upon-Tyne Hospitals NHS Trust

Unknown

Contractility: Cuff Versus Urodynamics Testing In Males With Voiding Lower Urinary Tract Symptoms (CONCUR)

Lower Urinary Tract Symptoms

United Kingdom
Newcastle-upon-Tyne Hospitals NHS Trust

Completed

Adenosine Testing to DEtermine the Need for Pacing Therapy (ADEPT-ILR)

Syncope

United Kingdom
Newcastle-upon-Tyne Hospitals NHS Trust

Completed

Assessment of Frailty in Patients With Advanced Hepatocellular Cancers (FAC-L)

Hepatocellular Cancer

United Kingdom
Newcastle-upon-Tyne Hospitals NHS Trust

Completed

Diagnosing Thyroid Cancer Using a Blood Test

Differentiated Thyroid Cancer

United Kingdom
Newcastle-upon-Tyne Hospitals NHS Trust

Completed

CD64 Measurement in Neonatal Infection and Necrotising Enterocolitis

Enterocolitis, Necrotizing | Neonatal SEPSIS

United Kingdom

Clinical Trials Sponsored by Tyme, Inc

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malaysia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations